Literature DB >> 19927135

Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan.

Pin-Hsuan Wu1, Chuh-Yuh Yang, Zhi-Lian Yao, Wei-Zhan Lin, Li-Wei Wu, Chih-Ching Chang.   

Abstract

BACKGROUND: Despite the efficacy of antihypertensive treatment in preventing cardiovascular complications, there are often problems with medication adherence in hypertensive patients. The objective of this study was to examine the medication adherence and its association with blood pressure (BP) control, cardiovascular disease (CVD) hospitalization, and all-cause hospitalization.
METHODS: We conducted a retrospective cohort observation of patients who were treated for hypertension from January 2005 to December 2006. Medical and pharmacy claims were obtained from Taiwan's National Health Insurance (NHI) database, whereas electronic records, including demographic characteristics and clinical information, were retrieved from a disease management program. To determine the degree of medication adherence, we calculated the proportion of days covered (PDC) by filled prescriptions. The associations of medication adherence with BP control, CVD hospitalization, and all-cause hospitalization were examined using multiple logistic regression models.
RESULTS: The study subjects comprised a total of 29,685 hypertensive patients. Of which, 40.1% of the patients had hypertension history of >5 years and 39.7% of patients had some comorbidity. In total, 85.5% of patients were categorized as adherent, with PDC >or=80; 60% of adherent patients had good BP control. Poor medication adherence was associated with poor BP control (odds ratio (OR) = 1.20, 1.13-1.29), CVD hospitalization (OR = 1.43, 1.14-1.81), and all-cause hospitalization (OR = 1.47, 1.21-1.78).
CONCLUSION: Our observation study clearly indicates that lower medication adherence is associated with poor BP control and higher risk of CVD and all-cause hospitalization in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19927135     DOI: 10.1038/ajh.2009.210

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  27 in total

1.  Multiple health behaviours: overview and implications.

Authors:  Bonnie Spring; Arlen C Moller; Michael J Coons
Journal:  J Public Health (Oxf)       Date:  2012-03       Impact factor: 2.341

2.  Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.

Authors:  Tara I Chang; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2010-09       Impact factor: 8.860

3.  Difference of antihypertensive prescribing between office- and hospital-based clinics in Taiwan.

Authors:  Wei-Liang Chen; Tung-Wei Kao; Chung-Ching Wang; Yaw-Wen Chang; Li-Wei Wu; Mark L Wahlqvist; Chih-Chieh Chou
Journal:  Int J Clin Pharm       Date:  2012-07-10

4.  The healthcare burden of hypertension in Asia.

Authors:  Chun-Na Jin; Cheuk-Man Yu; Jing-Ping Sun; Fang Fang; Yong-Na Wen; Ming Liu; Alex Pui-Wai Lee
Journal:  Heart Asia       Date:  2013-11-19

5.  Kidney function and long-term medication adherence after myocardial infarction in the elderly.

Authors:  Tara I Chang; Manisha Desai; Daniel H Solomon; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-13       Impact factor: 8.237

6.  [A prescription register incorporated into computerized medical records for patients with hypertension: a new instrument to evaluate medication adherence].

Authors:  José Miguel Baena-Díez; Claudia Gómez-Fernández; Mónica Vilató-García; Ernesto Javier Vásquez-Lazo; Alice Olivia Byram; Marc Vidal-Solsona
Journal:  Aten Primaria       Date:  2011-02-20       Impact factor: 1.137

7.  Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.

Authors:  Wei-Hsuan Lo-Ciganic; Julie M Donohue; Bobby L Jones; Subashan Perera; Joshua M Thorpe; Carolyn T Thorpe; Zachary A Marcum; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2016-05-26       Impact factor: 5.128

8.  Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.

Authors:  Manuel Wallbach; Nadine Lach; Johanna Stock; Henrik Hiller; Eirini Mavropoulou; Myra-Lynn Chavanon; Hartmud Neurath; Sabine Blaschke; Elena Lowin; Christoph Herrmann-Lingen; Gerhard A Müller; Michael J Koziolek
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-05       Impact factor: 3.738

9.  Clinical outcomes and healthcare costs in hypertensive patients treated with a fixed-dose combination of amlodipine/valsartan.

Authors:  Ying-Chang Tung; Yu-Sheng Lin; Lung-Sheng Wu; Chee-Jen Chang; Pao-Hsien Chu
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-12-05       Impact factor: 3.738

10.  Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension.

Authors:  Marcel Halbach; David Grothaus; Fabian Hoffmann; Navid Madershahian; Kathrin Kuhr; Hannes Reuter
Journal:  Clin Auton Res       Date:  2020-02-12       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.